Sensenig Bethany 4
4 · 9 METERS BIOPHARMA, INC. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Sensenig Bethany
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-18+1,300,000→ 1,300,000 totalExercise: $0.84Exp: 2032-01-18→ Common stock (1,300,000 underlying)
Footnotes (1)
- [F1]25% of these shares shall be deemed vested and exercisable on January 18, 2023 with the remainder vesting in equal monthly installments over the next 36 months, such that the option shall be fully vested on January 18, 2026, subject to the executive's continued service with the Company through each applicable vesting date.